• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problem Contamination (1120)
Patient Problem Nausea (1970)
Event Date 12/29/2022
Event Type  malfunction  
Manufacturer Narrative
Technical services provided the safety data sheet to the customer.The remainder of the investigation remains in progress.A supplemental report will be provided after completion.
 
Event Description
The consumer reported that the swab from the binaxnow covid-19 ag self-test kit felt sticky and smelled like glue when swabbing their nostril during sample collection.The consumer also reported that a ¿white substance¿ was coming out of her nostril after the swab was removed.The consumer stated she felt symptoms of nausea and wanted to know what medication she could take for the reported nausea.The consumer did not receive any medical attention afterwards.No additional patient information, including outcome, was provided.
 
Event Description
The consumer reported that the swab from the binaxnow covid-19 ag self-test kit felt sticky and smelled like glue when swabbing their nostril during sample collection.The consumer also reported that a ¿white substance¿ was coming out of her nostril after the swab was removed.The consumer stated she felt symptoms of nausea and wanted to know what medication she could take for the reported nausea.The consumer did not receive any medical attention afterwards.No additional patient information, including outcome, was provided.
 
Manufacturer Narrative
Technical services provided the safety data sheet to the customer.Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 213939 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-160 / lot: 213939, test base part number 195-430h / lot: 207636.The lot met the required release specifications.A review of the complaints reported as contaminated / used products (swab) related to kit lot 223939 showed that the complaint rate is (b)(4).Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue; however, it could possibly be related to the specific patient sample.D4: lot # expiration date extended.H3 other text : single use, device discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key16174959
MDR Text Key308494075
Report Number1221359-2023-00094
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public00811877011408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/03/2024
Device Catalogue Number195-160
Device Lot Number213939
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/29/2022
Initial Date FDA Received01/16/2023
Supplement Dates Manufacturer Received03/11/2023
Supplement Dates FDA Received03/16/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age37 YR
Patient SexFemale
Patient Weight61 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-